The N terminus of G protein-coupled receptors has been implicated in binding to peptide hormones. We have used random saturation mutagenesis to identify essential residues in the N terminus of the human complement factor 5a receptor (C5aR). In a library of N-terminal mutant C5aR molecules screened for activation by C5a, residues 24 -30 of the C5aR showed a marked propensity to mutate to cysteine, most likely indicating that sulfhydryl groups at these positions are appropriately situated to form disulfide interactions with the unpaired Cys 27 of human C5a. This presumptive spatial constraint allowed the ligand to be computationally docked to the receptor to form a model of the C5a/C5aR interaction. When the N-terminal mutant C5aR library was rescreened with C5a C27R, a ligand incapable of disulfide interactions, no individual position in the N terminus was essential for receptor signaling. However, the region 19 -29 was relatively highly conserved in the functional mutants, further demonstrating that this region of the C5aR makes a productive physiologic interaction with the C5a ligand.G protein-coupled receptors (GPCRs) 3 transduce signals from a wide variety of biological stimuli, including small molecules, lipids, peptides, proteins, and environmental cues such as odorants and light (1). As the largest family of cell-surface receptors, they have provided fertile ground for pharmacologic modulation. GPCRs share a secondary structure consisting of seven transmembrane helices (TMs 1-7) joined by three intracellular and three extracellular loops, along with N-and C-terminal domains (Fig. 1). The receptors serve as binary switches that, when activated by ligand, exhibit guanine nucleotide exchange factor activity toward heterotrimeric G proteins (2). Because they are large transmembrane proteins, GPCRs are difficult to study by direct structural methods such as x-ray crystallography. A series of crystal structures of bovine rhodopsin has allowed major progress in the understanding of GPCR structure (3-7) but has not made clear the mechanism by which these receptors serve as switches, because rhodopsin has only been crystallized in its resting state. The mechanism of GPCR activation has, however, been productively explored using a variety of biochemical, biophysical, and computational techniques. Overall, ligand binding by GPCRs appears to induce a rigid-body movement of TM6 away from TM3, exposing new receptor surfaces that allow coupling to downstream effectors (8 -11).Our laboratory has studied the human complement factor 5a receptor (C5aR) (12) as a model system because it, like rhodopsin and many other clinically important receptors, belongs to the large family A of GPCRs (13). The C5aR has 19% amino acid identity with rhodopsin and has loop and transmembrane helix lengths similar to those of rhodopsin. Furthermore, the C5aR can be expressed in Saccharomyces cerevisiae, making it amenable to genetic studies.In addition to its role as a model receptor, the C5aR has intrinsic biological interest. The vertebrate...